JP2008519070A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519070A5
JP2008519070A5 JP2007540284A JP2007540284A JP2008519070A5 JP 2008519070 A5 JP2008519070 A5 JP 2008519070A5 JP 2007540284 A JP2007540284 A JP 2007540284A JP 2007540284 A JP2007540284 A JP 2007540284A JP 2008519070 A5 JP2008519070 A5 JP 2008519070A5
Authority
JP
Japan
Prior art keywords
tablet
dosage form
layer
pharmaceutical dosage
coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007540284A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519070A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2005/001643 external-priority patent/WO2006049565A1/en
Publication of JP2008519070A publication Critical patent/JP2008519070A/ja
Publication of JP2008519070A5 publication Critical patent/JP2008519070A5/ja
Pending legal-status Critical Current

Links

JP2007540284A 2004-11-04 2005-11-02 プロトンポンプ阻害剤用の新規な改変された放出の錠剤製剤 Pending JP2008519070A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62564904P 2004-11-04 2004-11-04
PCT/SE2005/001643 WO2006049565A1 (en) 2004-11-04 2005-11-02 New modified release tablet formulations for proton pump inhibitors

Publications (2)

Publication Number Publication Date
JP2008519070A JP2008519070A (ja) 2008-06-05
JP2008519070A5 true JP2008519070A5 (enExample) 2008-12-11

Family

ID=36319458

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540284A Pending JP2008519070A (ja) 2004-11-04 2005-11-02 プロトンポンプ阻害剤用の新規な改変された放出の錠剤製剤

Country Status (17)

Country Link
US (1) US20080003281A1 (enExample)
EP (1) EP1809262A4 (enExample)
JP (1) JP2008519070A (enExample)
KR (1) KR20070083956A (enExample)
CN (1) CN101094661A (enExample)
AR (1) AR052225A1 (enExample)
AU (1) AU2005301369A1 (enExample)
BR (1) BRPI0517954A (enExample)
CA (1) CA2584419A1 (enExample)
IL (1) IL182686A0 (enExample)
MX (1) MX2007004987A (enExample)
NO (1) NO20072257L (enExample)
RU (1) RU2007115544A (enExample)
TW (1) TW200624126A (enExample)
UY (1) UY29193A1 (enExample)
WO (1) WO2006049565A1 (enExample)
ZA (1) ZA200703111B (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR051654A1 (es) * 2004-11-04 2007-01-31 Astrazeneca Ab Nuevas formulaciones de pellets de liberacion modificada para inhibidores de la bomba de protones
EP1970056A1 (en) * 2007-03-15 2008-09-17 Polichem S.A. Time-specific delayed/pulsatile release dosage forms
WO2009017716A2 (en) * 2007-07-27 2009-02-05 Depomed, Inc. Pulsatile gastric retentive dosage forms
ITFI20070253A1 (it) * 2007-11-09 2009-05-10 Valpharma Internat S P A Formulazioni farmaceutiche per la somministrazione di ipp.
US20090280173A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Omeprazole Tablets
US20090280175A1 (en) * 2008-05-09 2009-11-12 Ishwar Chauhan Multilayer Proton Pump Inhibitor Tablets
WO2011078993A1 (en) * 2009-12-21 2011-06-30 Aptapharma, Inc. Functionally-coated multilayer tablets
EP2384747A3 (en) * 2010-05-05 2012-01-18 Sanovel Ilac Sanayi ve Ticaret A.S. Oral Tablet Compositions Of Dexlansoprazole
EP2384746A3 (en) * 2010-05-05 2012-03-07 Sanovel Ilac Sanayi ve Ticaret A.S. Dual release oral tablet compositions of dexlansoprazole
US8563035B2 (en) 2010-05-05 2013-10-22 Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi Oral tablet compositions of dexlansoprazole
EP2384745A3 (en) * 2010-05-05 2012-01-18 Sanovel Ilac Sanayi ve Ticaret A.S. Modified release pharmaceutical compositions of dexlansoprazole
BR112013019791A2 (pt) * 2011-02-03 2016-10-25 Lupin Ltd composições farmacêuticas de bepotastina de liberação oral controlada
WO2012111024A1 (en) * 2011-02-18 2012-08-23 Suven Nishtaa Pharma Pvt Ltd Pharmaceutical compositions of dexlansoprazole
EP3288556A4 (en) 2015-04-29 2018-09-19 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CN104856971B (zh) * 2015-05-15 2019-05-14 暨南大学 一种脉冲双释放制剂及其制备方法与应用
CN105012274A (zh) * 2015-06-27 2015-11-04 上海信谊万象药业股份有限公司 一种奥美拉唑微片胶囊制剂及其制备方法
CN104940170A (zh) * 2015-07-23 2015-09-30 浙江亚太药业股份有限公司 一种埃索美拉唑镁肠溶胶囊及其制备方法
JP2019504024A (ja) * 2015-12-22 2019-02-14 インプリミス・ファーマシューティカルズ・インコーポレイテッドＩｍｐｒｉｍｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． 腎結石を治療する医薬製剤ならびにその製造方法および用法
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
KR101877350B1 (ko) * 2016-10-28 2018-08-09 한미약품 주식회사 에스오메프라졸 함유 복합 캡슐제 및 그 제조방법
JP6336651B1 (ja) * 2016-12-15 2018-06-06 大原薬品工業株式会社 化学的安定性が改善されたエソメプラゾール塩を含有する錠剤
WO2019030610A1 (en) * 2017-08-11 2019-02-14 Solutions In Innovative Research Pvt. Ltd. PHARMACEUTICAL COMPOSITIONS WITH DUAL DIRECTLY COMPRESSIBLE MEDICAMENT RELEASE

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL75400A (en) * 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
US4704285A (en) * 1985-11-18 1987-11-03 The Dow Chemical Company Sustained release compositions comprising hydroxypropyl cellulose ethers
IT1230576B (it) * 1988-10-20 1991-10-28 Angeli Inst Spa Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US20050054682A1 (en) * 1996-01-04 2005-03-10 Phillips Jeffrey O. Pharmaceutical compositions comprising substituted benzimidazoles and methods of using same
SE9600072D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients II
AU5179898A (en) * 1996-11-06 1998-05-29 Sharmatek, Inc. Delayed delivery system for acid-sensitive drugs
US5885616A (en) * 1997-08-18 1999-03-23 Impax Pharmaceuticals, Inc. Sustained release drug delivery system suitable for oral administration
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
DK1126826T6 (en) * 1998-11-02 2019-06-24 Alkermes Pharma Ireland Ltd Multiparticulate modified release of methylphenidate
US6632451B2 (en) * 1999-06-04 2003-10-14 Dexcel Pharma Technologies Ltd. Delayed total release two pulse gastrointestinal drug delivery system
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
EP1074249A1 (en) * 1999-07-27 2001-02-07 Jagotec Ag A pharmaceutical tablet system for releasing at least one active substance during a release period subsequent to a no-release period
ES2168043B1 (es) * 1999-09-13 2003-04-01 Esteve Labor Dr Forma farmaceutica solida oral de liberacion modificada que contiene un compuesto de bencimidazol labil en medio acido.
GB9923436D0 (en) * 1999-10-04 1999-12-08 American Home Prod Pharmaceutical compositions
US20030180352A1 (en) * 1999-11-23 2003-09-25 Patel Mahesh V. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6627223B2 (en) * 2000-02-11 2003-09-30 Eurand Pharmaceuticals Ltd. Timed pulsatile drug delivery systems
US6749867B2 (en) * 2000-11-29 2004-06-15 Joseph R. Robinson Delivery system for omeprazole and its salts
WO2003026626A2 (en) * 2001-09-28 2003-04-03 Mcneil-Ppc, Inc. Modified release dosage forms
JP2003171277A (ja) * 2001-12-07 2003-06-17 Wyeth Lederle Japan Ltd 薬物放出時間制御型固形製剤
AU2003250468A1 (en) * 2002-08-16 2004-03-03 Themis Laboratories Private Limited A process for manufacture of stable oral multiple units pharamceutical composition containing benzimidazoles
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
EP1596838A2 (en) * 2003-02-11 2005-11-23 Torrent Pharmaceuticals Ltd Once a day orally administered pharmaceutical compositions comprising a proton pump inhibitor and a prokinetic agent
US7670624B2 (en) * 2004-01-29 2010-03-02 Astella Pharma Inc. Gastrointestinal-specific multiple drug release system
AU2005249367A1 (en) * 2004-04-16 2005-12-15 Santarus, Inc. Combination of proton pump inhibitor, buffering agent, and prokinetic agent

Similar Documents

Publication Publication Date Title
JP2008519070A5 (enExample)
KR101752014B1 (ko) 고용량 및 저용량 약물들의 조합을 포함하는 구강붕해정 조성물
JP4638964B2 (ja) プロトンポンプ阻害剤およびｎｓａｉｄからなる経口用医薬剤形
JP6976946B2 (ja) 生理活性の強い、ｕｒａｔ１のインヒビターを含む医薬組成物
JP2004501190A5 (enExample)
JP2012518655A5 (enExample)
JP2015098477A (ja) 弱塩基性薬物を含む組成物及び徐放性剤形
JP2001526213A (ja) 経口医薬パルス放出剤形
JP2002527468A (ja) 脈動用量薬剤経口送達システム
TW200522981A (en) Immediate-release formulation of acid-labile pharmaceutical compositions
KR20080098627A (ko) 약 염기성 선택성 세로토닌 5-ｈｔ3 차단제와 유기산을 포함하는 약물 전달 시스템
AU2007266574A1 (en) Multiple unit pharmaceutical formulation
TWI388316B (zh) 抑制胃酸分泌之組合物及方法
IE61166B1 (en) Pharmaceutical formulations of acrivastine
CN100362996C (zh) 一种度洛西汀肠溶微丸胶囊及其制备方法
HUP0201687A2 (en) Oral administration form for administering a fixed tramadol and diclofenac combination
JP2014533656A5 (enExample)
TW200803871A (en) New combination dosage form
RU2007115544A (ru) Новые препараты ингибиторов протонного насоса в виде таблеток с модифицированным высвобождением
JPWO2001023000A1 (ja) 消化管下部溶解性コーティング製剤
CN101808665A (zh) 阿利吉仑和缬沙坦的药物组合
JP2018118936A (ja) 腸溶層破損防止用組成物
JP2008519069A5 (enExample)
JPH032119A (ja) メベベリン投薬形
CN105073100A (zh) 坦索罗辛或其盐的药物组合物